Pasar al contenido principal

ANALISIS INTEGRADO DE LAS INTERACCIONES ENTRE LA GLUCEMIA Y LA COMPOSICION DE LA MICROBIOTA, Y DE SU IMPACTO SOBRE EL ACUMULO DE HIERRO CEREBRAL Y LA COGNICION EN SUJETOS OBESOS

PI18/01022

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INV. DR. JOSEP TRUETA
Centro realización INSTITUTO DE INVESTIGACION BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased brain fractional perfusion in obesity using intravoxel incoherent motion (IVIM) MRI metrics

  • Motger Albertí, Anna|||0000-0002-9430-371X
  • de la Calle, Elena
  • Giménez, Mònica
  • Blasco, Gerard|||0000-0002-5302-0625
  • Biarnés, Carles|||0000-0002-6604-2014
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Puig, Josep|||0000-0003-2791-6599
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objective: This research seeks to shed light on the associations between brain perfusion, cognitive function, and mental health in individuals with and without obesity. Methods: In this study, we employed the noninvasive intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) technique to examine brain fractional perfusion (FP) in two groups: individuals with obesity (N = 72) and healthy controls (N = 66). Additionally, we investigated potential associations between FP, cognitive function, and depressive symptoms in the participants with and without obesity. Finally, artificial intelligence algorithms (Boruta analysis) were also used. Results: Participants with obesity exhibited increased FP within dopaminergic brain circuits, particularly involving prefrontal cortex areas, anterior and posterior sections of the cingulate cortex, the right striatum, and the midbrain. Additionally, these individuals demonstrated lower working memory and higher depressive symptoms compared to the control group. Notably, higher FP in the inferior temporal and occipital cortices correlated with greater depressive symptoms, whereas increased FP in the right ventral caudate and the midbrain was associated with better working memory performance. A link between inflammatory and metabolic variables, with a particular emphasis on monocytes, and FP in obesity was also evidenced by Boruta analysis. Conclusions: Increased brain perfusion in individuals with obesity is associated with cognitive function and mental health through interaction with metabolic and inflammatory factors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lower serum ferritin levels are associated with worse cognitive performance in aging

  • Rosell-Díaz, Marisel|||0000-0001-7599-6584
  • Santos-González, Elena
  • Motger Albertí, Anna|||0000-0002-9430-371X
  • Gallardo-Nuell, Laura
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Ramió-Torrentà, Lluís|||0000-0002-6999-1004
  • Garre-Olmo, Josep|||0000-0002-7817-0814
  • Puig, Josep|||0000-0003-2791-6599
  • Ramos, Rafel|||0000-0001-7970-5537
  • Mayneris-Perxachs, Jordi|||0000-0003-3788-3815
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objectives: Iron is important for neurogenesis, synaptic development, and neurotransmitter synthesis. Serum ferritin (SF) is a reliable marker for assessing iron stores. Therefore, we evaluated the cognitive function associated with SF levels. We also assessed brain iron content using R2* Magnetic Resonance Imaging (MRI) and its association with SF levels. Design: Data from three cross-sectional observational studies were used. Aging Imageomics (n = 1030) was conducted on aged subjects. Health Imageomics (n = 971) and IR0NMET (n = 175) were conducted in middle-aged subjects. Setting and participants: Participants were enrolled at Dr. Josep Trueta University Hospital facilities. The three cohorts included a total of 2176 subjects (mean age, 52 years; 48% men). Measurements: SF levels were measured by standard laboratory methods. Total Digits Span (TDS), and Phonemic Verbal Fluency (PVF) were used to assess executive function. Language function was assessed by semantic verbal fluency (SVF), attention by the Symbol Digit Modalities Test, and memory by the Memory Binding Tests - Total Free Recall and Total Delayed Free Recall. MRI was used to assess the iron content of the brain by R2*. Results: In subjects aged 65 years or older, SF levels were associated with increased TDS (β = 0.003, p = 0.02), PVF (β = 0.004, p = 0.01), and SVF (β = 0.004, p = 0.002) scores. After stratification by sex, these findings were significant only in men, where SF was associated with increased TDS (β = 0.003, p = 0.01), PVF (β = 0.004, p = 0.03), and SVF (β = 0.004, p = 0.009) scores. In middle-aged subjects, SF was also associated with increased SVF scores (β = 0.005, p = 0.011). Lastly, in men, SF levels were negatively associated with R2*, a surrogate marker of brain iron content, in both the left frontal inferior opercular area (r = -0.41, p = 0.005) and the right frontal inferior opercular area (r = -0.44, p = 0.002). Conclusions: SF is significantly and positively associated with cognition. In older people with low SF levels, iron supplementation may be a promising therapy to improve cognition.